The present invention provides methods and compositions for the
interventional pharmacogenomics. The invention is based modifying an
environment in a subject that is non-receptive to a therapeutic agent,
such that the increased expression of a heterologous protein that
interacts with the therapeutic agent, produces an environment that is
receptive to the therapeutic agent, thereby making the therapy
efficacious in the subject.
